Attila Dobi, Ph.D. - Publications

Affiliations: 
2014 Physics University of Maryland, College Park, College Park, MD 

26/105 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bradley A, Bramante R, Cahn SB, Carmona-Benitez MC, Chan C, ... ... Dobi A, et al. Results on the Spin-Dependent Scattering of Weakly Interacting Massive Particles on Nucleons from the Run 3 Data of the LUX Experiment. Physical Review Letters. 116: 161302. PMID 27152786 DOI: 10.1103/Physrevlett.116.161302  0.517
2016 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bradley A, Bramante R, Cahn SB, Carmona-Benitez MC, Chan C, ... ... Dobi A, et al. Improved Limits on Scattering of Weakly Interacting Massive Particles from Reanalysis of 2013 LUX Data. Physical Review Letters. 116: 161301. PMID 27152785 DOI: 10.1103/Physrevlett.116.161301  0.56
2016 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bradley A, Bramante R, Cahn SB, Carmona-Benitez MC, Chan C, ... ... Dobi A, et al. Results on the Spin-Dependent Scattering of Weakly Interacting Massive Particles on Nucleons from the Run 3 Data of the LUX Experiment Physical Review Letters. 116. DOI: 10.1103/PhysRevLett.116.161302  0.517
2016 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bradley A, Bramante R, Cahn SB, Carmona-Benitez MC, Chan C, ... ... Dobi A, et al. Improved Limits on Scattering of Weakly Interacting Massive Particles from Reanalysis of 2013 LUX Data Physical Review Letters. 116. DOI: 10.1103/PhysRevLett.116.161301  0.561
2016 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bradley A, Bramante R, Cahn SB, Carmona-Benitez MC, Chan C, ... ... Dobi A, et al. Tritium calibration of the LUX dark matter experiment Physical Review D - Particles, Fields, Gravitation and Cosmology. 93. DOI: 10.1103/Physrevd.93.072009  0.52
2016 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bradley A, Bramante R, Cahn SB, Carmona-Benitez MC, Chan C, ... ... Dobi A, et al. FPGA-based trigger system for the LUX dark matter experiment Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 818: 57-67. DOI: 10.1016/J.Nima.2016.02.017  0.533
2015 Horn M, Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bernard E, Bernstein A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, Chiller AA, ... ... Dobi A, et al. Results from the LUX dark matter experiment Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 784: 504-507. DOI: 10.1016/J.Nima.2014.11.033  0.565
2015 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bernard E, Bernstein A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, Chiller AA, Chiller C, ... ... Dobi A, et al. Radiogenic and muon-induced backgrounds in the LUX dark matter detector Astroparticle Physics. 62: 33-46. DOI: 10.1016/J.Astropartphys.2014.07.009  0.534
2014 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bedikian S, Bernard E, Bernstein A, Bolozdynya A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, ... ... Dobi A, et al. First results from the LUX dark matter experiment at the Sanford underground research facility. Physical Review Letters. 112: 091303. PMID 24655239 DOI: 10.1103/Physrevlett.112.091303  0.546
2014 Albert JB, Auger M, Auty DJ, Barbeau PS, Beauchamp E, Beck D, Belov V, Benitez-Medina C, Bonatt J, Breidenbach M, Brunner T, Burenkov A, Cao GF, Chambers C, Chaves J, ... ... Dobi A, et al. Improved measurement of the 2 ν β β half-life of 136 Xe with the EXO-200 detector Physical Review C - Nuclear Physics. 89. DOI: 10.1103/Physrevc.89.015502  0.744
2013 Akerib DS, Bai X, Bedikian S, Bernard E, Bernstein A, Bolozdynya A, Bradley A, Byram D, Cahn SB, Camp C, Carmona-Benitez MC, Carr D, Chapman JJ, Chiller A, Chiller C, ... ... Dobi A, et al. The Large Underground Xenon (LUX) experiment Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 704: 111-126. DOI: 10.1016/J.Nima.2012.11.135  0.557
2013 Akerib DS, Bai X, Bernard E, Bernstein A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chapman JJ, Coffey T, Dobi A, Dragowsky E, Druszkiewicz E, Edwards B, Faham CH, et al. Technical results from the surface run of the LUX dark matter experiment Astroparticle Physics. 45: 34-43. DOI: 10.1016/J.Astropartphys.2013.02.001  0.534
2012 Auger M, Auty DJ, Barbeau PS, Beauchamp E, Belov V, Benitez-Medina C, Breidenbach M, Brunner T, Burenkov A, Cleveland B, Cook S, Daniels T, Danilov M, Davis CG, Delaquis S, ... ... Dobi A, et al. Search for neutrinoless double-beta decay in 136Xe with EXO-200. Physical Review Letters. 109: 032505. PMID 22861843 DOI: 10.1103/Physrevlett.109.032505  0.768
2012 Auger M, Auty DJ, Barbeau PS, Beauchamp E, Belov V, Benitez-Medina C, Breidenbach M, Brunner T, Burenkov A, Cleveland B, Cook S, Daniels T, Danilov M, Davis CG, Delaquis S, ... ... Dobi A, et al. Search for neutrinoless double-beta decay in Xe136 with EXO-200 Physical Review Letters. 109. DOI: 10.1103/PhysRevLett.109.032505  0.767
2012 Auger M, Auty DJ, Barbeau PS, Bartoszek L, Baussan E, Beauchamp E, Benitez-Medina C, Breidenbach M, Chauhan D, Cleveland B, Conley R, Cook J, Cook S, Coppens A, Craddock W, ... ... Dobi A, et al. The EXO-200 detector, part I: Detector design and construction Journal of Instrumentation. 7. DOI: 10.1088/1748-0221/7/05/P05010  0.778
2012 Akerib DS, Bai X, Bedikian S, Bernard E, Bernstein A, Bradley A, Cahn SB, Carmona-Benitez MC, Carr D, Chapman JJ, Clark K, Classen T, Coffey T, Dazeley S, De Viveiros L, ... Dobi A, et al. LUXSim: A component-centric approach to low-background simulations Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 675: 63-77. DOI: 10.1016/J.Nima.2012.02.010  0.461
2012 Dobi A, Hall C, Slutsky S, Yen YR, Aharmin B, Auger M, Barbeau PS, Benitez-Medina C, Breidenbach M, Cleveland B, Conley R, Cook J, Cook S, Counts I, Craddock W, et al. Xenon purity analysis for EXO-200 via mass spectrometry Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 675: 40-46. DOI: 10.1016/J.Nima.2012.01.066  0.775
2011 Ackerman N, Aharmim B, Auger M, Auty DJ, Barbeau PS, Barry K, Bartoszek L, Beauchamp E, Belov V, Benitez-Medina C, Breidenbach M, Burenkov A, Cleveland B, Conley R, Conti E, ... ... Dobi A, et al. Observation of two-neutrino double-beta decay in 136Xe with the EXO-200 detector. Physical Review Letters. 107: 212501. PMID 22181874 DOI: 10.1103/Physrevlett.107.212501  0.773
2011 LePort F, Neilson R, Barbeau PS, Barry K, Bartoszek L, Counts I, Davis J, deVoe R, Dolinski MJ, Gratta G, Green M, Montero Díez M, Müller AR, O'Sullivan K, Rivas A, ... ... Dobi A, et al. A magnetically driven piston pump for ultra-clean applications. The Review of Scientific Instruments. 82: 105114. PMID 22047336 DOI: 10.1063/1.3653391  0.739
2011 Ackerman N, Aharmim B, Auger M, Auty DJ, Barbeau PS, Barry K, Bartoszek L, Beauchamp E, Belov V, Benitez-Medina C, Breidenbach M, Burenkov A, Cleveland B, Conley R, Conti E, ... ... Dobi A, et al. Observation of two-neutrino double-beta decay in Xe136 with the EXO-200 detector Physical Review Letters. 107. DOI: 10.1103/PhysRevLett.107.212501  0.781
2011 Sinclair D, Rollin E, Smith J, Mommers A, Ackeran N, Aharmin B, Auger M, Barbeau PS, Benitez-Medina C, Breidenbach M, Burenkov A, Cook S, Coppens A, Daniels T, De Devoe R, ... Dobi A, et al. Prospects for barium tagging in gaseous xenon Journal of Physics: Conference Series. 309. DOI: 10.1088/1742-6596/309/1/012005  0.69
2011 Dobi A, Davis C, Hall C, Langford T, Slutsky S, Yen YR. Detection of krypton in xenon for dark matter applications Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 665: 1-6. DOI: 10.1016/J.Nima.2011.11.043  0.765
2011 Dobi A, Hall C, Herrin S, Odian A, Prescott CY, Rowson PC, Ackerman N, Aharmin B, Auger M, Barbeau PS, Barry K, Benitez-Medina C, Breidenbach M, Cook S, Counts I, et al. A xenon gas purity monitor for EXO Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 659: 215-228. DOI: 10.1016/J.Nima.2011.09.017  0.768
2010 Leonard DS, Dobi A, Hall C, Kaufman LJ, Langford T, Slutsky S, Yen YR. A simple high-sensitivity technique for purity analysis of xenon gas Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 621: 678-684. DOI: 10.1016/J.Nima.2010.04.152  0.742
2010 Dobi A, Leonard DS, Hall C, Kaufman LJ, Langford T, Slutsky S, Yen YR. Study of a zirconium getter for purification of xenon gas Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 620: 594-598. DOI: 10.1016/J.Nima.2010.03.151  0.739
2009 Slutsky S, Yen YR, Breuer H, Dobi A, Hall C, Langford T, Leonard DS, Kaufman LJ, Strickland V, Voskanian N. A xenon condenser with a remote liquid storage vessel Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 610: 669-676. DOI: 10.1016/J.Nima.2009.09.029  0.737
Low-probability matches (unlikely to be authored by this person)
2015 Faham CH, Gehman VM, Currie A, Dobi A, Sorensen P, Gaitskell RJ. Measurements of wavelength-dependent double photoelectron emission from single photons in VUV-sensitive photomultiplier tubes Journal of Instrumentation. 10. DOI: 10.1088/1748-0221/10/09/P09010  0.134
2014 Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bedikian S, Bernard E, Bernstein A, Bolozdynya A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, ... ... Dobi A, et al. First results from the LUX dark matter experiment at the sanford underground research facility Physical Review Letters. 112. DOI: 10.1103/PhysRevLett.112.091303  0.125
2015 He J, Schepmoes AA, Shi T, Wu C, Fillmore TL, Gao Y, Smith RD, Qian WJ, Rodland KD, Liu T, Camp DG, Rastogi A, Tan SH, Yan W, Mohamed AA, ... ... Dobi A, et al. Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods. Journal of Translational Medicine. 13: 54. PMID 25889691 DOI: 10.1186/S12967-015-0418-Z  0.097
2013 Szász AM, Majoros A, Rosen P, Srivastava S, Dobi A, SzendrÅ‘i A, Kulka J, Nyirády P. Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma. International Urology and Nephrology. 45: 727-33. PMID 23686669 DOI: 10.1007/S11255-013-0406-2  0.08
2011 Sharad S, Srivastava A, Ravulapalli S, Parker P, Chen Y, Li H, Petrovics G, Dobi A. Prostate cancer gene expression signature of patients with high body mass index. Prostate Cancer and Prostatic Diseases. 14: 22-9. PMID 21060327 DOI: 10.1038/pcan.2010.44  0.077
1997 Dobi A, Palkovits M, Ring MA, Eitel A, Palkovits CG, Lim F, Agoston DV. Sample and probe: a novel approach for identifying development-specific cis-elements of the enkephalin gene. Brain Research. Molecular Brain Research. 52: 98-111. PMID 9450682 DOI: 10.1016/S0169-328X(97)00238-6  0.065
1997 Dobi A, Mahan MA, v Agoston D. Detection of conformation bias between the complementary strands of deoxynucleotide repeat (TG/AC)n. Electrophoresis. 18: 12-6. PMID 9059814 DOI: 10.1002/elps.1150180104  0.064
2015 Nickens KP, Ali A, Scoggin T, Tan SH, Ravindranath L, McLeod DG, Dobi A, Tacha D, Sesterhenn IA, Srivastava S, Petrovics G. Prostate cancer marker panel with single cell sensitivity in urine. The Prostate. 75: 969-75. PMID 25808739 DOI: 10.1002/pros.22981  0.062
2006 Torosyan Y, Dobi A, Naga S, Mezhevaya K, Glasman M, Norris C, Jiang G, Mueller G, Pollard H, Srivastava M. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription. Cancer Research. 66: 9609-16. PMID 17018618 DOI: 10.1158/0008-5472.CAN-06-1574  0.052
2003 Le Y, Gagneten S, Larson T, Santha E, Dobi A, v Agoston D, Sauer B. Far-upstream elements are dispensable for tissue-specific proenkephalin expression using a Cre-mediated knock-in strategy. Journal of Neurochemistry. 84: 689-97. PMID 12562513 DOI: 10.1046/j.1471-4159.2003.01573.x  0.048
2014 Rastogi A, Tan SH, Mohamed AA, Chen Y, Hu Y, Petrovics G, Sreenath T, Kagan J, Srivastava S, McLeod DG, Sesterhenn IA, Srivastava S, Dobi A, Srinivasan A. Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer. Genes & Cancer. 5: 273-84. PMID 25221645 DOI: 10.18632/GENESANDCANCER.25  0.045
2010 Dobi A, Margolis EB, Wang HL, Harvey BK, Morales M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 218-29. PMID 20053904 DOI: 10.1523/Jneurosci.3884-09.2010  0.039
2007 Agoston DV, Szemes M, Dobi A, Palkovits M, Georgopoulos K, Gyorgy A, Ring MA. Ikaros is expressed in developing striatal neurons and involved in enkephalinergic differentiation. Journal of Neurochemistry. 102: 1805-16. PMID 17504264 DOI: 10.1111/J.1471-4159.2007.04653.X  0.038
2015 Li H, Mohamed AA, Sharad S, Umeda E, Song Y, Young D, Petrovics G, McLeod DG, Sesterhenn IA, Sreenath T, Dobi A, Srivastava S. Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN. Oncotarget. 6: 15137-49. PMID 25883222  0.037
2008 Kawakami R, Dobi A, Shigemoto R, Ito I. Right isomerism of the brain in inversus viscerum mutant mice. Plos One. 3: e1945. PMID 18414654 DOI: 10.1371/journal.pone.0001945  0.035
1998 Dobi A, v Agoston D. Submillimolar levels of calcium regulates DNA structure at the dinucleotide repeat (TG/AC)n. Proceedings of the National Academy of Sciences of the United States of America. 95: 5981-6. PMID 9600903 DOI: 10.1073/pnas.95.11.5981  0.033
2011 McLeod DG, Dobi A. Words of wisdom. Re: Antibody-based detection of ERG rearrangement-positive prostate cancer. European Urology. 60: 1123. PMID 21961743 DOI: 10.1016/j.eururo.2011.08.036  0.033
2010 Furusato B, Tan SH, Young D, Dobi A, Sun C, Mohamed AA, Thangapazham R, Chen Y, McMaster G, Sreenath T, Petrovics G, McLeod DG, Srivastava S, Sesterhenn IA. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer and Prostatic Diseases. 13: 228-37. PMID 20585344 DOI: 10.1038/pcan.2010.23  0.032
2006 Sun C, Shi Y, Xu LL, Nageswararao C, Davis LD, Segawa T, Dobi A, McLeod DG, Srivastava S. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival. Oncogene. 25: 3905-13. PMID 16636679 DOI: 10.1038/sj.onc.1209424  0.031
2011 Mohamed AA, Tan SH, Sun C, Shaheduzzaman S, Hu Y, Petrovics G, Chen Y, Sesterhenn IA, Li H, Sreenath T, McLeod DG, Dobi A, Srivastava S. ERG oncogene modulates prostaglandin signaling in prostate cancer cells. Cancer Biology & Therapy. 11: 410-7. PMID 21178489 DOI: 10.4161/cbt.11.4.14180  0.031
2005 Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Furasato B, Sun C, Chen Y, Nau M, Ravindranath L, Chen Y, Dobi A, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene. 24: 3847-52. PMID 15750627 DOI: 10.1038/sj.onc.1208518  0.03
1995 Dobi A, Dameron CT, Hu S, Hamer D, Winge DR. Distinct regions of Cu(I).ACE1 contact two spatially resolved DNA major groove sites. The Journal of Biological Chemistry. 270: 10171-8. PMID 7730320 DOI: 10.1074/Jbc.270.17.10171  0.03
2006 Dobi A, Szemes M, Lee C, Palkovits M, Lim F, Gyorgy A, Mahan MA, Agoston DV. AUF1 is expressed in the developing brain, binds to AT-rich double-stranded DNA, and regulates enkephalin gene expression. The Journal of Biological Chemistry. 281: 28889-900. PMID 16769718 DOI: 10.1074/jbc.M511858200  0.028
2015 Dubovenko A, Serebryiskaya T, Nikolsky Y, Nikolskaya T, Perlina A, JeBailey L, Bureeva S, Katta S, Srivastava S, Dobi A, Khasanova T. Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors. Journal of Cancer. 6: 490-501. PMID 26000039 DOI: 10.7150/jca.8213  0.028
2014 Thangapazham R, Saenz F, Katta S, Mohamed AA, Tan SH, Petrovics G, Srivastava S, Dobi A. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer. Bmc Cancer. 14: 16. PMID 24418414 DOI: 10.1186/1471-2407-14-16  0.027
2008 Sterbis JR, Gao C, Furusato B, Chen Y, Shaheduzzaman S, Ravindranath L, Osborn DJ, Rosner IL, Dobi A, McLeod DG, Sesterhenn IA, Srivastava S, Cullen J, Petrovics G. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 758-63. PMID 18245536 DOI: 10.1158/1078-0432.CCR-07-1356  0.027
1986 Laskay G, Lehoczki E, Dobi AL, Szalay L. Photosynthetic characteristics of detached barley leaves during greening in the presence of SAN 9785. Planta. 169: 123-9. PMID 24232437 DOI: 10.1007/BF01369783  0.026
2014 Mygatt J, Sesterhenn I, Rosner I, Chen Y, Cullen J, Morris-Gore T, Barton J, Dobi A, Srivastava S, McLeod D, Brassell SA. Anterior tumors of the prostate: clinicopathological features and outcomes. Prostate Cancer and Prostatic Diseases. 17: 75-80. PMID 24296774 DOI: 10.1038/pcan.2013.54  0.025
2011 Miettinen M, Wang ZF, Paetau A, Tan SH, Dobi A, Srivastava S, Sesterhenn I. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. The American Journal of Surgical Pathology. 35: 432-41. PMID 21317715 DOI: 10.1097/Pas.0B013E318206B67B  0.025
1995 Dobi AL, Palkovits M, Palkovits CG, Santha E, van Agoston D. Protein-DNA interactions during phenotypic differentiation. Molecular Neurobiology. 10: 185-203. PMID 7576307 DOI: 10.1007/BF02740675  0.025
2010 McMullin RP, Dobi A, Mutton LN, Orosz A, Maheshwari S, Shashikant CS, Bieberich CJ. A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland. Proceedings of the National Academy of Sciences of the United States of America. 107: 98-103. PMID 20018680 DOI: 10.1073/Pnas.0902001107  0.025
2013 Dobi A, Sartori SB, Busti D, Van der Putten H, Singewald N, Shigemoto R, Ferraguti F. Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice. Neuropharmacology. 66: 274-89. PMID 22643400 DOI: 10.1016/j.neuropharm.2012.05.025  0.025
1986 Laskay G, Lehoczki E, Dobi AL, Szalay L. Effects of Pyridazinone Herbicides during Chloroplast Development in Detached Barley Leaves: III. Effects of SAN 6706 on Photosynthetic Activity and Chlorophyll-Protein Complexes Zeitschrift Fur Naturforschung - Section C Journal of Biosciences. 41: 585-590. DOI: 10.1515/znc-1986-5-616  0.025
2005 Masuda K, Werner T, Maheshwari S, Frisch M, Oh S, Petrovics G, May K, Srikantan V, Srivastava S, Dobi A. Androgen receptor binding sites identified by a GREF_GATA model. Journal of Molecular Biology. 353: 763-71. PMID 16213525 DOI: 10.1016/j.jmb.2005.09.009  0.024
2012 Braun M, Goltz D, Shaikhibrahim Z, Vogel W, Böhm D, Scheble V, Sotlar K, Fend F, Tan SH, Dobi A, Kristiansen G, Wernert N, Perner S. ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies. Prostate Cancer and Prostatic Diseases. 15: 165-9. PMID 22231490 DOI: 10.1038/pcan.2011.67  0.024
2012 Derosa CA, Furusato B, Shaheduzzaman S, Srikantan V, Wang Z, Chen Y, Seifert M, Siefert M, Ravindranath L, Young D, Nau M, Dobi A, Werner T, McLeod DG, Vahey MT, et al. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression. Prostate Cancer and Prostatic Diseases. 15: 150-6. PMID 22343836 DOI: 10.1038/pcan.2011.61  0.024
2011 Lee GL, Dobi A, Srivastava S. Prostate cancer: diagnostic performance of the PCA3 urine test. Nature Reviews. Urology. 8: 123-4. PMID 21394175 DOI: 10.1038/nrurol.2011.10  0.023
2010 Srivastava A, Mousses S, Dobi A, Leighton X. Elevated expression of the cytochrome b561, a neuroendocrine vesicle protein, in castration resistant prostate tumors. Cancer Biomarkers : Section a of Disease Markers. 7: 17-23. PMID 21045261 DOI: 10.3233/CBM-2010-0142  0.023
2014 Tan SH, Furusato B, Fang X, He F, Mohamed AA, Griner NB, Sood K, Saxena S, Katta S, Young D, Chen Y, Sreenath T, Petrovics G, Dobi A, McLeod DG, et al. Evaluation of ERG responsive proteome in prostate cancer. The Prostate. 74: 70-89. PMID 24115221 DOI: 10.1002/Pros.22731  0.023
2014 Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A, deVere White RW, Kung HJ. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene. 33: 2495-503. PMID 23728339 DOI: 10.1038/onc.2013.200  0.022
1998 v Agoston D, Santha E, Shieh G, Lala R, Dobi A. Isolation and structural and genetic analysis of the mouse enkephalin gene and its d(AC/TG)n repeats. Dna Sequence : the Journal of Dna Sequencing and Mapping. 9: 217-26. PMID 10520752 DOI: 10.3109/10425179809105208  0.022
2008 Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG, Dobi A, Srivastava S, Petrovics G, Sesterhenn IA. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 67-75. PMID 18065961 DOI: 10.1038/modpathol.3800981  0.022
2006 Szemes M, Gyorgy A, Paweletz C, Dobi A, Agoston DV. Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain. Neurochemical Research. 31: 237-46. PMID 16604441 DOI: 10.1007/s11064-005-9012-8  0.021
2014 Sharad S, Ravindranath L, Haffner MC, Li H, Yan W, Sesterhenn IA, Chen Y, Ali A, Srinivasan A, McLeod DG, Yegnasubramanian S, Srivastava S, Dobi A, Petrovics G. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer. Epigenetics : Official Journal of the Dna Methylation Society. 9: 918-27. PMID 24694733 DOI: 10.4161/Epi.28710  0.02
2011 Dobi A, Seabold GK, Christensen CH, Bock R, Alvarez VA. Cocaine-induced plasticity in the nucleus accumbens is cell specific and develops without prolonged withdrawal. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 1895-904. PMID 21289199 DOI: 10.1523/Jneurosci.5375-10.2011  0.018
2010 Mohamed AA, Tan SH, Mikhalkevich N, Ponniah S, Vasioukhin V, Bieberich CJ, Sesterhenn IA, Dobi A, Srivastava S, Sreenath TL. Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody. Journal of Cancer. 1: 197-208. PMID 21060730 DOI: 10.7150/Jca.1.197  0.018
2012 Rosen P, Pfister D, Young D, Petrovics G, Chen Y, Cullen J, Böhm D, Perner S, Dobi A, McLeod DG, Sesterhenn IA, Srivastava S. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. Urology. 80: 749-53. PMID 22950997 DOI: 10.1016/j.urology.2012.07.001  0.018
2008 Furusato B, Shaheduzzaman S, Petrovics G, Dobi A, Seifert M, Ravindranath L, Nau ME, Werner T, Vahey M, McLeod DG, Srivastava S, Sesterhenn IA. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. Prostate Cancer and Prostatic Diseases. 11: 194-7. PMID 17768422 DOI: 10.1038/sj.pcan.4501007  0.018
2011 Kramer PF, Christensen CH, Hazelwood LA, Dobi A, Bock R, Sibley DR, Mateo Y, Alvarez VA. Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 126-32. PMID 21209197 DOI: 10.1523/Jneurosci.4287-10.2011  0.017
2008 Thangapazham RL, Shaheduzzaman S, Kim KH, Passi N, Tadese A, Vahey M, Dobi A, Srivastava S, Maheshwari RK. Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome. Cancer Biology & Therapy. 7: 1427-35. PMID 18719366 DOI: 10.1016/S0022-5347(08)60553-4  0.017
2015 Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, ... ... Dobi A, et al. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. Ebiomedicine. 2: 1957-64. PMID 26844274 DOI: 10.1016/J.Ebiom.2015.10.028  0.016
2000 Dobi A, Palkovits M, Palkovits CG, Ring MA, Agoston D. Septamer element-binding proteins in neuronal and glial differentiation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 1073-84. PMID 10648713  0.016
2007 Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod D, ... ... Dobi A, et al. Silencing of Lactotransferrin expression by methylation in prostate cancer progression. Cancer Biology & Therapy. 6: 1088-95. PMID 17568188  0.015
2008 Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, Shaheduzzaman S, Tan SH, Vaidyanathan G, Whitman E, Hawksworth DJ, Chen Y, Nau M, Patel V, Vahey M, et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene. 27: 5348-53. PMID 18542058 DOI: 10.1038/onc.2008.183  0.015
1956 JUBA A, DOBI A. [Hemiballism; clinical, cerebrosurgical and histopathological contribution]. Monatsschrift Fã¼R Psychiatrie Und Neurologie. 132: 48-61. PMID 13348543  0.014
2008 Hu Y, Dobi A, Sreenath T, Cook C, Tadase AY, Ravindranath L, Cullen J, Furusato B, Chen Y, Thangapazham RL, Mohamed A, Sun C, Sesterhenn IA, McLeod DG, Petrovics G, et al. Delineation of TMPRSS2-ERG splice variants in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4719-25. PMID 18676740 DOI: 10.1158/1078-0432.CCR-08-0531  0.014
2014 Gsponer JR, Braun M, Scheble VJ, Zellweger T, Bachmann A, Perner S, Vlajnic T, Srivastava M, Tan SH, Dobi A, Sesterhenn IA, Srivastava S, Bubendorf L, Ruiz C. ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17: 126-31. PMID 24469092 DOI: 10.1038/pcan.2013.62  0.012
1994 Dobi AL, Matsumoto K, Santha E, v Agoston D. Guanine specific chemical sequencing of DNA by osmium tetroxide. Nucleic Acids Research. 22: 4846-7. PMID 7984442 DOI: 10.1093/nar/22.22.4846  0.012
2016 Kumar P, Sharad S, Petrovics G, Mohamed A, Dobi A, Sreenath TL, Srivastava S, Biswas R. Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1 Oncotarget. 7: 22791-22806. DOI: 10.18632/oncotarget.8061  0.012
2010 Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, Ali A, Ravindranath L, Dobi A, Sesterhenn IA, Sestrehenn IA, McLeod DG, Srivastava S, Freedman M, Petrovics G. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1-8. PMID 20056617 DOI: 10.1158/1055-9965.EPI-08-1111  0.012
2012 Dobi A, Sreenath T, Srivastava S. Androgen-dependent oncogenic activation of ETS transcription factors by recurrent gene fusions in prostate cancer: Biological and clinical implications Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 307-328. DOI: 10.1007/978-1-4614-6182-1_19  0.012
2009 Brassell SA, Dobi A, Petrovics G, Srivastava S, McLeod D. The Center for Prostate Disease Research (CPDR): a multidisciplinary approach to translational research. Urologic Oncology. 27: 562-9. PMID 19720304 DOI: 10.1016/j.urolonc.2009.01.023  0.012
2010 Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, Ali A, Ravindranath L, Dobi A, Sesterhenn IA, McLeod DG, Srivastava S, Freedman M, Petrovics G. Prostate cancer risk allele specific for african descent associates with pathologic stage at prostatectomy (Cancer Epidemiology, Biomarkers & Prevention (2010), 19 (1-8)) Cancer Epidemiology Biomarkers and Prevention. 19: 890. DOI: 10.1158/1055-9965.EPI-10-0016  0.011
2013 Bock R, Shin JH, Kaplan AR, Dobi A, Markey E, Kramer PF, Gremel CM, Christensen CH, Adrover MF, Alvarez VA. Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use. Nature Neuroscience. 16: 632-8. PMID 23542690 DOI: 10.1038/Nn.3369  0.011
2011 Dobi Á, Kelemen G, Kaizer L, Weiczner R, Thurzó L, Kahán Z. Breast cancer under 40 years of age: increasing number and worse prognosis. Pathology Oncology Research : Por. 17: 425-8. PMID 20848250 DOI: 10.1007/s12253-010-9305-3  0.011
2015 Griner NB, Young D, Chaudhary P, Mohamed AA, Huang W, Chen Y, Sreenath T, Dobi A, Petrovics G, Vishwanatha JK, Sesterhenn IA, Srivastava S, Tan SH. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. Molecular Cancer Research : McR. 13: 368-79. PMID 25344575 DOI: 10.1158/1541-7786.Mcr-14-0275-T  0.011
2010 Dobi A, Furusato B, Shaheduzzaman S, Chen Y, Vahey M, Nydam T, Sesterhenn IA, McLeod DG, Petrovics G, Srivastava S. ERG expression levels in prostate tumors reflect functional status of the androgen receptor (AR) as a consequence of fusion of ERG with AR regulated gene promoters Open Cancer Journal. 3: 101-108.  0.01
2012 Rosen P, Sesterhenn IA, Brassell SA, McLeod DG, Srivastava S, Dobi A. Clinical potential of the ERG oncoprotein in prostate cancer. Nature Reviews. Urology. 9: 131-7. PMID 22331093 DOI: 10.1038/nrurol.2012.10  0.01
2011 Sreenath TL, Dobi A, Petrovics G, Srivastava S. Oncogenic activation of ERG: A predominant mechanism in prostate cancer. Journal of Carcinogenesis. 10: 37. PMID 22279422 DOI: 10.4103/1477-3163.91122  0.01
2010 Torosyan Y, Dobi A, Glasman M, Mezhevaya K, Naga S, Huang W, Paweletz C, Leighton X, Pollard HB, Srivastava M. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells. Oncogene. 29: 2457-66. PMID 20190808 DOI: 10.1038/onc.2010.2  0.01
2009 Tsunoda T, Furusato B, Takashima Y, Ravulapalli S, Dobi A, Srivastava S, McLeod DG, Sesterhenn IA, Ornstein DK, Shirasawa S. The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma. The Prostate. 69: 1398-403. PMID 19479898 DOI: 10.1002/pros.20988  0.01
2008 Li H, Xu LL, Masuda K, Raymundo E, McLeod DG, Dobi A, Srivastava S. A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. The Journal of Biological Chemistry. 283: 28988-95. PMID 18703514 DOI: 10.1074/jbc.M710528200  0.01
2007 Richter E, Masuda K, Cook C, Ehrich M, Tadese AY, Li H, Owusu A, Srivastava S, Dobi A. A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer. Epigenetics : Official Journal of the Dna Methylation Society. 2: 100-9. PMID 18174752  0.01
2007 Richter E, Srivastava S, Dobi A. Androgen receptor and prostate cancer. Prostate Cancer and Prostatic Diseases. 10: 114-8. PMID 17297502 DOI: 10.1038/sj.pcan.4500936  0.01
2007 Kim KH, Dobi A, Shaheduzzaman S, Gao CL, Masuda K, Li H, Drukier A, Gu Y, Srikantan V, Rhim JS, Srivastava S. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase. Prostate Cancer and Prostatic Diseases. 10: 30-8. PMID 17075604 DOI: 10.1038/sj.pcan.4500915  0.01
2002 Dobi A, Debnam W, Dalgard C, Owusu A, von Agoston D. Mammalian expression cloning of nucleic acid binding proteins by agarose thin-layer gelshift clone selection. Biotechniques. 33: 868-72. PMID 12398195  0.01
2000 Agoston DV, Dobi A. Complexity of transcriptional control in neuropeptide gene expression; enkephalin gene regulation during neurodevelopment. Biochemical Society Transactions. 28: 446-51. PMID 10961937  0.01
1990 Kálmán M, Cserpán I, Bajszár G, Dobi A, Horváth E, Pázmán C, Simoncsits A. Synthesis of a gene for human serum albumin and its expression in Saccharomyces cerevisiae. Nucleic Acids Research. 18: 6075-81. PMID 2235491 DOI: 10.1093/nar/18.20.6075  0.01
1956 Juba A, Dobi A. Der Hemiballismus (klinisch-hirnchirurgischer und histopathologischer Beitrag) European Neurology. 132: 48-61. DOI: 10.1159/000139622  0.01
Hide low-probability matches.